XTENT, Inc. (XTNT)

CAPS Rating:

A development stage medical device company, which focused on developing and commercializing its customizable drug eluting stent systems for the treatment of coronary artery disease or CAD.

View Ticker Page (XTNT)

Results 1 - 7 of 7 : 1

Recs

1

Avatar 80brown (99.01) Submitted: 6/01/07 3:44 PM : Start Price: $9.60 XTNT Score: 56.72

Trading at 324% intrinsic value.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar kurzzz (81.25) Submitted: 3/22/07 3:44 PM : Start Price: $12.58 XTNT Score: -72.16

Undervalued!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar nguyenvanh (< 20) Submitted: 6/29/07 5:24 PM : Start Price: $10.07 XTNT Score: -60.20

Strong cash. High potential.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar Hopper39 (< 20) Submitted: 10/24/07 11:26 AM : Start Price: $9.75 XTNT Score: -59.69

Customizable drug eluting stent (DES) system targeting treatment of coronary artery disease (CAD), the most common form of cardiovascular disease and the number 1 cause of death in Europe and the United States.

Per recent BW article, Chase estima...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar TakeAction (< 20) Submitted: 11/08/07 6:14 PM : Start Price: $10.36 XTNT Score: -64.52

Medical device are about building either a new or better "mouse trap". XTNT has developed a better one than the current stents on the market.

But, they can't go it alone. Too small to effectively compete with the big boys. ...

Report this Post Replies: 0 | Reply | Permalink